VRM
TMDI

Vectors Research Management’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Vectors Research Management’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,500
Closed -$2K – 574
2019
Q4 		$2K Hold
3,500
– – ﹤0.01% 508
2019
Q3 		$4K Hold
3,500
– – ﹤0.01% 392
2019
Q2 		$8K Buy
3,500
+1,000
+40% +$2.5K ﹤0.01% 294
2019
Q1 		$7K Buy
+2,500
New +$8.19K ﹤0.01% 309

Other funds holding TMDI

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
COF
Capital One Financial Mclean, Virginia $141M AUM 2.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Vectors Research Management's TMDI Position: Q1 2020 in Review

Vectors Research Management sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2020, closing a stake of 3,500 shares — an estimated $2K sold.

Vectors Research Management first reported a position in TMDI in Q1 2019 and held it in 4 quarters. The position peaked at $8K in Q2 2019. 39 funds tracked by Wall St. Rank hold TMDI as of Q1 2020.

  • Vectors Research Management reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Vectors Research Management sold 3,500 Titan Medical Inc. Ordinary Shares shares in Q1 2020, an estimated $2K.
  • Vectors Research Management first reported a position in Titan Medical Inc. Ordinary Shares in Q1 2019 and held it in 4 quarters.
  • Vectors Research Management's Titan Medical Inc. Ordinary Shares position peaked at $8K in Q2 2019.
  • 39 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2020.

Based on Vectors Research Management's 13F filing for Q1 2020, filed 14 May 2020.